|
Jul 1
|
GSK Rebranded Flovent Asthma Inhaler For Children To Avoid $367 Million Medicaid Rebate, Senator Hassan Accuses
|
|
Jun 30
|
Gilead extends gains after Supreme Court upheld an Obamacare provision
|
|
Jun 28
|
GSK (GSK) Gains FDA Approval for Benlysta Autoinjector for Lupus Treatment
|
|
Jun 27
|
Gilead, Exact Jump After The Supreme Court Upholds A 'Cornerstone' Of Health Care
|
|
Jun 26
|
Ephicacy Appoints Névine Zariffa to Its Board of Directors
|
|
Jun 25
|
Bharat, GSK to halve price of malaria vaccine by 2028
|
|
Jun 24
|
EMA Accepts GSK's Filing for Linerixibat in Rare Disease-Related Itch
|
|
Jun 24
|
FDA approves Benlysta (belimumab) Autoinjector for children with active lupus nephritis
|
|
Jun 23
|
GSK (GSK) is a Top-Ranked Value Stock: Should You Buy?
|
|
Jun 19
|
FDA Approves Gilead's Twice-Yearly Shot for HIV Prevention
|
|
Jun 18
|
GSK Stock Rises Almost 22% in 6 Months: Time to Buy, Sell or Hold?
|
|
Jun 17
|
Here's Why GSK (GSK) is a Strong Momentum Stock
|
|
Jun 17
|
GSK Licenses Shigella Vaccine to Bharat Biotech
|
|
Jun 7
|
Patents and economies of scale support Pfizer's wide moat
|
|
Jun 5
|
Myriad (MYGN) Up 23.9% Since Last Earnings Report: Can It Continue?
|
|
Jun 3
|
How Moderna Went From Pandemic Hero to Vaccine Victim
|
|
Jun 2
|
Theravance Biopharma, Inc. Sells Remaining Royalty Interest in Trelegy Ellipta to GSK for $225 Million
|
|
May 23
|
GSK (LSE:GSK) Secures FDA Approval For COPD Treatment, Eyes European Nod For Blenrep
|
|
May 22
|
Nucala (mepolizumab) approved by US FDA for use in adults with chronic obstructive pulmonary disease (COPD)
|
|
May 19
|
GSK’s Blood-Cancer Treatment Combinations Approved in Japan
|